Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay
Kahimmune Therapeutics has signed an exclusive licensing agreement with Gustave [...]
A newly published benchmark dataset is helping push variant detection [...]